中国男科学杂志
中國男科學雜誌
중국남과학잡지
CHINESE JOURNAL OF ANDROLOGY
2013年
4期
46-49
,共4页
张晔%李爱华*%吴文美%陆鸿海%张峰%刘思宽%王晖%钱小强%张炳辉%方炜
張曄%李愛華*%吳文美%陸鴻海%張峰%劉思寬%王暉%錢小彊%張炳輝%方煒
장엽%리애화*%오문미%륙홍해%장봉%류사관%왕휘%전소강%장병휘%방위
经尿道前列腺切除术%老年人%85岁以上%生活质量
經尿道前列腺切除術%老年人%85歲以上%生活質量
경뇨도전렬선절제술%노년인%85세이상%생활질량
transurethral resection of the prostate%aged,85 over%quality of life
目的评估85岁以上超高龄BPH患者经尿道前列腺电汽化切除术(TUVRP)的手术风险和术后生存状态.方法55例85岁以上施行TUVRP患者(A组)与228例80岁以下患者(B组和C组)进行回顾性比较.A组55例85~97岁,平均年龄(87.91±2.70)岁;B组137例71~80岁;C组91例60~70岁.结果美国麻醉学会(ASA)评分A组高于B组和C组,与B组和C组相比,差异均具统计学意义(P≤0.05);手术时间A组为(40.03±18.90) min,与B组和C组比较差异无统计学意义(P>0.05).A组术后34例存活者日常生活和行为能力(Barthel)指数(66.0±17.46),其中18例(52.94%)评分>60;10例(29.41%)评分41~60;6例(17.65%)评分<40.A组31例国际前列腺症状评分(IPSS)11.35±7.04,与B组比较差异无统计学意义(P>0.05).与C组相比具统计学意义(P<0.01).生活质量评分(QoL)1.23±0.76,均低于B组和C组,差异均具统计学意义P<0.05.结论85岁以上BPH患者手术风险高于80岁以下.大部分患者术后可获得满意排尿功能和保持较好的日常生活能力.一次安全的TUVRP手术能够改善85岁以上BPH患者的日常生活能力和生活质量.
目的評估85歲以上超高齡BPH患者經尿道前列腺電汽化切除術(TUVRP)的手術風險和術後生存狀態.方法55例85歲以上施行TUVRP患者(A組)與228例80歲以下患者(B組和C組)進行迴顧性比較.A組55例85~97歲,平均年齡(87.91±2.70)歲;B組137例71~80歲;C組91例60~70歲.結果美國痳醉學會(ASA)評分A組高于B組和C組,與B組和C組相比,差異均具統計學意義(P≤0.05);手術時間A組為(40.03±18.90) min,與B組和C組比較差異無統計學意義(P>0.05).A組術後34例存活者日常生活和行為能力(Barthel)指數(66.0±17.46),其中18例(52.94%)評分>60;10例(29.41%)評分41~60;6例(17.65%)評分<40.A組31例國際前列腺癥狀評分(IPSS)11.35±7.04,與B組比較差異無統計學意義(P>0.05).與C組相比具統計學意義(P<0.01).生活質量評分(QoL)1.23±0.76,均低于B組和C組,差異均具統計學意義P<0.05.結論85歲以上BPH患者手術風險高于80歲以下.大部分患者術後可穫得滿意排尿功能和保持較好的日常生活能力.一次安全的TUVRP手術能夠改善85歲以上BPH患者的日常生活能力和生活質量.
목적평고85세이상초고령BPH환자경뇨도전렬선전기화절제술(TUVRP)적수술풍험화술후생존상태.방법55례85세이상시행TUVRP환자(A조)여228례80세이하환자(B조화C조)진행회고성비교.A조55례85~97세,평균년령(87.91±2.70)세;B조137례71~80세;C조91례60~70세.결과미국마취학회(ASA)평분A조고우B조화C조,여B조화C조상비,차이균구통계학의의(P≤0.05);수술시간A조위(40.03±18.90) min,여B조화C조비교차이무통계학의의(P>0.05).A조술후34례존활자일상생활화행위능력(Barthel)지수(66.0±17.46),기중18례(52.94%)평분>60;10례(29.41%)평분41~60;6례(17.65%)평분<40.A조31례국제전렬선증상평분(IPSS)11.35±7.04,여B조비교차이무통계학의의(P>0.05).여C조상비구통계학의의(P<0.01).생활질량평분(QoL)1.23±0.76,균저우B조화C조,차이균구통계학의의P<0.05.결론85세이상BPH환자수술풍험고우80세이하.대부분환자술후가획득만의배뇨공능화보지교호적일상생활능력.일차안전적TUVRP수술능구개선85세이상BPH환자적일상생활능력화생활질량.
Objective To evaluate surgical risk of transurethral vaporization resection of the prostate (TUVRP) and postoperative quality of living status in patients over 85 years of age with benign prostate hyperplasia (BPH). Methods Fifty five patients over 85 years old with BPH who underwent TUVRP were compared with 228 patients below 80 years old. There were 55 patients aged from 85 to 97 years old, with mean age 87.91± 2.70 years in Group A , 137 patients aged from 71 to 80 year old in Group B, and 91 patients aged from 60 to 70 year old in Group C. Results Preoperative ASA grade in Group A was higher than that of the other two groups (P≤0.05), but no obvious difference in operating time ( 40.03± 18.90)min (P >0.05). Follow-up was obtained in 44 (80.00%) patients; of them 10 patients were deaths with a survival time of 22.90 ± 11.14 months. For 34 survivors in groupA, barthel index score was 66.03±17.46, and for 18 of them (52.94%), score was >60; Score of 10 (29.41%) patients was 41-60 and 6 (17.65%) patients was <40. IPSS score of 34 patients in group A was 11.35±7.04, there was a significant difference in IPSS score compared with that of Group C (P<0.01). QOL index was 1.23±0.76, there was a significant differnece compared with that of the other two groups (P<0.05). Conclusion TUVRP surgical risk in patients over 85 years old is higher than that in patients below 80 years old. But most patients over 85 years old had satisfactory voiding function and better activities in daily living after TUVRP. A safety TUVRP could improve their activities of daily living and quality of life.